FUREN Group Pharmaceutical Co., Ltd. announced earnings results for the half year ended June 30, 2019. For the half year, the company announced sales was CNY 2,768.963 million compared to CNY 3,108.659 million a year ago. Operating income was CNY 511.639 million compared to CNY 560.678 million a year ago. Net income was CNY 399.002 million compared to CNY 450.577 million a year ago. Basic earnings per share from continuing operations was CNY 0.64 compared to CNY 0.72 a year ago.